NLRC4 suppresses melanoma tumor progression independently of inflammasome activation.
Janowski AM, Colegio OR, Hornick EE, McNiff JM, Martin MD, Badovinac VP, Norian LA, Zhang W, Cassel SL, Sutterwala FS.
Janowski AM, et al. Among authors: badovinac vp.
J Clin Invest. 2016 Oct 3;126(10):3917-3928. doi: 10.1172/JCI86953. Epub 2016 Sep 12.
J Clin Invest. 2016.
PMID: 27617861
Free PMC article.